Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Lung Cancer

  Free Subscription


10.07.2017

2 Ann Thorac Surg
6 Anticancer Res
3 BMC Cancer
1 Br J Cancer
1 Cancer
3 Clin Cancer Res
3 Clin Lung Cancer
1 Clin Nucl Med
2 Int J Radiat Oncol Biol Phys
1 J Clin Oncol
1 J Thorac Cardiovasc Surg
5 Lancet Oncol
7 Lung Cancer
1 Oncol Rep
2 PLoS One
1 Thorax


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. GRIGOR EJM, Ivanovic J, Anstee C, Zhang Z, et al
    Impact of Adverse Events and Length of Stay on Patient Experience After Lung Cancer Resection.
    Ann Thorac Surg. 2017 Jun 29. pii: S0003-4975(17)30700.
    PubMed     Text format     Abstract available

  2. WOLF AS, Swanson SJ, Yip R, Liu B, et al
    The Impact of Margins on Outcomes After Wedge Resection for Stage I Non-Small Cell Lung Cancer.
    Ann Thorac Surg. 2017 Jun 29. pii: S0003-4975(17)30586.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. OTSUKA T, Nojiri T, Minami S, Hosoda H, et al
    Evaluation of Natriuretic Peptide in Non-small Cell Lung Cancer Patients Treated with Bevacizumab Together with Carboplatin-Paclitaxel: A Prospective Study.
    Anticancer Res. 2017;37:3505-3512.
    PubMed     Text format     Abstract available

  4. PANCEWICZ-WOJTKIEWICZ J, Bernatowicz PL
    The Effect of Afatinib Treatment in Non-small Cell Lung Cancer Cells.
    Anticancer Res. 2017;37:3543-3546.
    PubMed     Text format     Abstract available

  5. SHEN TC, Hsia TC, Chao CY, Chen WC, et al
    The Contribution of MMP-8 Promoter Polymorphisms in Lung Cancer.
    Anticancer Res. 2017;37:3563-3567.
    PubMed     Text format     Abstract available

  6. BANNA GL, Parra HJS, Castaing M, Dieci MV, et al
    Histology-based Combination Induction Chemotherapy for Elderly Patients with Clinical Stage III Non-small Cell Lung Cancer.
    Anticancer Res. 2017;37:3723-3728.
    PubMed     Text format     Abstract available

  7. NAKAO M, Muramatsu H, Kagawa Y, Suzuki Y, et al
    Immunological Status May Predict Response to Nivolumab in Non-small Cell Lung Cancer without Driver Mutations.
    Anticancer Res. 2017;37:3781-3786.
    PubMed     Text format     Abstract available

  8. YOTSUMOTO F, Fukagawa S, Miyata K, Nam SO, et al
    HB-EGF Is a Promising Therapeutic Target for Lung Cancer with Secondary Mutation of EGFRT790M.
    Anticancer Res. 2017;37:3825-3831.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. KIM EY, Jung JY, Kim A, Kim K, et al
    Methionyl-tRNA synthetase overexpression is associated with poor clinical outcomes in non-small cell lung cancer.
    BMC Cancer. 2017;17:467.
    PubMed     Text format     Abstract available

  10. WANG JZ, Xiang JJ, Wu LG, Bai YS, et al
    A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis.
    BMC Cancer. 2017;17:167.
    PubMed     Text format     Abstract available

  11. ZHOU Q, Song Y, Zhang X, Chen GY, et al
    A multicenter survey of first-line treatment patterns and gene aberration test status of patients with unresectable Stage IIIB/IV nonsquamous non-small cell lung cancer in China (CTONG 1506).
    BMC Cancer. 2017;17:462.
    PubMed     Text format     Abstract available


    Br J Cancer

  12. WINTHER-LARSEN A, Demuth C, Fledelius J, Madsen AT, et al
    Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients.
    Br J Cancer. 2017 Jul 6. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  13. RWIGEMA JM, Verma V, Lin L, Berman AT, et al
    Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
    Cancer. 2017 Jul 5. doi: 10.1002/cncr.30870.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  14. ADAMS DL, Adams DK, He J, Kalhor N, et al
    Sequential tracking of PD-L1 expression and RAD50 induction in circulating tumor and stromal cells of lung cancer patients undergoing radiotherapy.
    Clin Cancer Res. 2017 Jul 5. pii: clincanres.0802.2017.
    PubMed     Text format     Abstract available

  15. NISHINO M, Dahlberg SE, Adeni AE, Lydon C, et al
    Tumor response dynamics of advanced non-small-cell lung cancer patients treated with PD-1 inhibitors: Imaging markers for treatment outcome.
    Clin Cancer Res. 2017 Jul 5. pii: clincanres.1434.2017.
    PubMed     Text format     Abstract available

  16. GRAY JE, Heist RS, Starodub AN, Camidge DR, et al
    Therapy of Small-cell Lung Cancer (SCLC) With a Topoisomerase-I-inhibiting Antibody-Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan.
    Clin Cancer Res. 2017 Jul 5. pii: clincanres.0933.2017.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  17. SADOYAMA S, Sekine A, Satoh H, Iwasawa T, et al
    Isolated Brain Metastases as the First Relapse After the Curative Surgical Resection in Non-Small-Cell Lung Cancer Patients With an EGFR Mutation.
    Clin Lung Cancer. 2017 Jun 1. pii: S1525-7304(17)30166.
    PubMed     Text format     Abstract available

  18. YAMAMOTO N, Kenmotsu H, Yamanaka T, Nakamura S, et al
    Randomized Phase III Study of Cisplatin With Pemetrexed and Cisplatin With Vinorelbine for Completely Resected Nonsquamous Non-Small-Cell Lung Cancer: The JIPANG Study Protocol.
    Clin Lung Cancer. 2017 Jun 8. pii: S1525-7304(17)30169.
    PubMed     Text format     Abstract available

  19. CHO JH, Sorensen SF, Choi YL, Feng Y, et al
    Programmed Death Ligand 1 Expression in Paired Non-Small Cell Lung Cancer Tumor Samples.
    Clin Lung Cancer. 2017 Apr 24. pii: S1525-7304(17)30113.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  20. GAO R, Gao S, Feng J, Wang Y, et al
    Diffuse Thyroid Metastasis From Lung Cancer Mimicking Thyroiditis on 99mTc-Pertechnetate Scintigraphy.
    Clin Nucl Med. 2017 Jul 6. doi: 10.1097/RLU.0000000000001755.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  21. MILLER JA, Bennett EE, Xiao R, Kotecha R, et al
    Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2016 Sep 1. pii: S0360-3016(16)33154.
    PubMed     Text format     Abstract available

  22. SPERDUTO PW, Yang TJ, Beal K, Pan H, et al
    The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2016;96:406-13.
    PubMed     Text format     Abstract available


    J Clin Oncol

  23. BENDZSAK AM, Baxter NN, Darling GE, Austin PC, et al
    Regionalization and Outcomes of Lung Cancer Surgery in Ontario, Canada.
    J Clin Oncol. 2017 Jul 6:JCO2016698076. doi: 10.1200/JCO.2016.69.8076.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  24. BRANDT WS, Isbell JM, Jones DR
    Defining quality in the surgical care of lung cancer patients.
    J Thorac Cardiovasc Surg. 2017 Jun 9. pii: S0022-5223(17)31171.
    PubMed     Text format    


    Lancet Oncol

  25. AKAMATSU H, Takahashi T, Yamamoto N
    Prophylactic cranial irradiation in small-cell lung cancer - Authors' reply.
    Lancet Oncol. 2017;18:e369.
    PubMed     Text format    

  26. MANAPOV F, Eze C
    Prophylactic cranial irradiation in small-cell lung cancer.
    Lancet Oncol. 2017;18:e366.
    PubMed     Text format    

  27. WEISS GJ, Lohinai Z
    Prophylactic cranial irradiation in small-cell lung cancer.
    Lancet Oncol. 2017;18:e367.
    PubMed     Text format    

  28. FAN X, Liang F, Zhu J
    Prophylactic cranial irradiation in small-cell lung cancer.
    Lancet Oncol. 2017;18:e368.
    PubMed     Text format    

  29. RUSTHOVEN CG, Kavanagh BD
    Prophylactic cranial irradiation in small-cell lung cancer.
    Lancet Oncol. 2017;18:e365.
    PubMed     Text format    


    Lung Cancer

  30. KIM SH, Hyun JW, Kim HJ, Gwak HS, et al
    De novo cystic brain lesions mimicking neurocysticercosis in ALK-positive lung cancer.
    Lung Cancer. 2017;110:53-55.
    PubMed     Text format     Abstract available

  31. DICKHOFF C, Dahele M, Smit EF, Paul MA, et al
    Patterns of care and outcomes for stage IIIB non-small cell lung cancer in the TNM-7 era: Results from the Netherlands Cancer Registry.
    Lung Cancer. 2017;110:14-18.
    PubMed     Text format     Abstract available

  32. SANDS J, Li Q, Hornberger J
    Urine circulating-tumor DNA (ctDNA) detection of acquired EGFR T790M mutation in non-small-cell lung cancer: An outcomes and total cost-of-care analysis.
    Lung Cancer. 2017;110:19-25.
    PubMed     Text format     Abstract available

  33. KOBAYASHI-WATANABE N, Sato A, Watanabe T, Abe T, et al
    Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
    Lung Cancer. 2017;110:35-41.
    PubMed     Text format     Abstract available

  34. TAO MH, Dai Q, Chen S, Freudenheim JL, et al
    Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative.
    Lung Cancer. 2017;110:42-47.
    PubMed     Text format     Abstract available

  35. LIAO BC, Lin CC, Lee JH, Yang JC, et al
    Optimal management of EGFR-mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy.
    Lung Cancer. 2017;110:7-13.
    PubMed     Text format     Abstract available

  36. KIM EY, Kim A, Kim SK, Chang YS, et al
    MYC expression correlates with PD-L1 expression in non-small cell lung cancer.
    Lung Cancer. 2017;110:63-67.
    PubMed     Text format     Abstract available


    Oncol Rep

  37. KIM GT, Kim SY, Kim YM
    Torilis japonica extract fraction compound, EGFR-targeted inhibition of cancer abnormal metastasis in A549 lung cancer cells.
    Oncol Rep. 2017 Jun 30. doi: 10.3892/or.2017.5771.
    PubMed     Text format     Abstract available


    PLoS One

  38. LEE AF, Chen MC, Chen CJ, Yang CJ, et al
    Reverse epithelial-mesenchymal transition contributes to the regain of drug sensitivity in tyrosine kinase inhibitor-resistant non-small cell lung cancer cells.
    PLoS One. 2017;12:e0180383.
    PubMed     Text format     Abstract available

  39. GUISIER F, Bohn P, Patout M, Piton N, et al
    In- and ex-vivo molecular imaging of apoptosis to assess sensitivity of non-small cell lung cancer to EGFR inhibitors using probe-based confocal laser endomicroscopy.
    PLoS One. 2017;12:e0180576.
    PubMed     Text format     Abstract available


    Thorax

  40. WATSON N
    Radiation exposure during lung cancer diagnostic work-up: how important in the wider picture?
    Thorax. 2017 Jul 5. pii: thoraxjnl-2017-210360.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: